M&A Deal Summary |
|
|---|---|
| Date | 2025-02-26 |
| Target | Novartis - Natural Products and Genetic Strains Assets |
| Sector | Agriculture |
| Buyer(s) | Syngenta AG |
| Sellers(s) | Novartis |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Chemicals |
| Employees | 28,000 |
| Revenue | 13.4B USD (2015) |
Syngenta is a global provider of chemicals and herbicides to enhance crop yields. Syngenta was formed in 1999 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 12 |
| Sector: Agriculture M&A | 6 of 6 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-30 |
Verisem
Amsterdam, Netherlands Verisem is a producer, packer, and distributor of specialty vegetable seeds for the professional, semiprofessional, and hobby garden markets around the world, and a contract supplier to a diverse set of global seed companies. Verisem is based in Amsterdam, Netherlands. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 104,323 |
| Revenue | 51.8B USD (2024) |
Novartis is a healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Agriculture M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 7 of 7 |
| Country: Switzerland M&A | 6 of 6 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-11 |
Anthos Therapeutics
Boston, Massachusetts, United States Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated therapies for high-risk cardiovascular patient populations. Anthos Therapeutics was founded in 2019 and is based in Boston, Massachusetts. |
Buy | $3.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-30 |
Regulus Therapeutics
San Diego, California, United States Regulus Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus Therapeutics was founded in 2007 and is based in San Diego, California. |
Buy | $800M |
